AC1-IN-1（Cat No.:I043976）is a selective small-molecule inhibitor targeting acetyl-CoA carboxylase 1 (ACC1), an enzyme involved in fatty acid metabolism and energy homeostasis. ACC1 plays a critical role in lipid biosynthesis, making it an attractive target for diseases associated with dysregulated lipid metabolism, such as cancer, obesity, and type 2 diabetes. By inhibiting ACC1, AC1-IN-1 disrupts fatty acid synthesis, leading to reduced tumor cell growth and metabolic changes that can promote therapeutic effects. AC1-IN-1 is being explored for its potential in treating metabolic disorders and cancer, particularly in combination with other therapies.